Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
St Antonius Hospital in Nieuwegein, the Netherlands, uses a soluble interleukin-2 receptor (sIL-2R) ELISA from Tecan in the investigation, management and monitoring of interstitial lung disease. This easy-to-use assay is the world’s first...
The quantification of unique proteins within biological samples has traditionally required thousands, tens of thousands or even millions of cells, with no way to identify cellular heterogeneity within the populations. To overcome this issue,...
The vaccine development process has transformed dramatically in recent years, driven by the urgent need for effective immunization against emerging contagious diseases. Traditional pipelines for the creation of novel vaccines relied on more than 10...